WHO ICTRP trial
A clinical trial to study the effects of two radiotherapy schedules…
CTRI/2018/04/013174 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2018/04/013174 |
|---|---|
| Public title | A clinical trial to study the effects of two radiotherapy schedules, conventional and hypofractionated, following mastectomy operation in female breast cancer patients with locally advanced disease |
| Scientific title | A RANDOMISED PROSPECTIVE STUDY COMPARING THE EFFICACY AND ACCEPTABILITY OF HYPOFRACTIONATED SCHEDULE VS CONVENTIONAL SCHEDULE OF ADJUVANT RADIOTHERAPY IN FEMALE BREAST CANCER - HFRT in LABC |
| Primary sponsor | Dr Partha Pratim Medhi |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: null- Adjuvant Radiotherapy in Female Breast Cancer Patients |
| Interventions | Intervention1: Hypofractionated Radiotherapy: 40 Gy in 15 fractions over 3 weeks at 267 cGy per fraction daily Control Intervention1: Conventional Radiotherapy: 50 Gy in 25 fractions over 5 weeks at 200 cGy per fraction daily |
| Registration date | Nov 4, 2018 |
| Target size | 50 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: